City Therapeutics Appoints Keith Regnante, MBA, as Chief Financial Officer and Mary Beth DeLena, J.D., as Chief Legal Officer

Written by Guest User

https://investors.citytx.com/news-releases/news-release-details/city-therapeutics-appoints-keith-regnante-mba-chief-financial

Guest User
Previous

City Therapeutics Announces Pricing of Upsized Initial Public Offering
Next

City Therapeutics Announces $99.5 Million Series B Financing to Advance Next-Generation RNAi Therapeutics